{"id":18235,"date":"2024-12-16T10:41:30","date_gmt":"2024-12-16T02:41:30","guid":{"rendered":"https:\/\/flcube.com\/?p=18235"},"modified":"2024-12-16T10:41:33","modified_gmt":"2024-12-16T02:41:33","slug":"neusoft-medical-systems-and-nmpa-collaborate-on-ai-enhanced-drug-administration","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=18235","title":{"rendered":"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration"},"content":{"rendered":"\n<p>Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic agreement with the Center for Information of the National Medical Products Administration (NMPA) of China. The collaboration aims to conduct in-depth research, innovative application, and practice exploration of artificial intelligence (AI) in the realm of drug intelligent administration. The joint efforts will be centered around the &#8220;AI+drug intelligent administration&#8221; R&amp;D application platform.<\/p>\n\n\n\n<p><strong>Leveraging Neusoft&#8217;s Technological Expertise in AI and Big Data<\/strong><br>This partnership will capitalize on Neusoft&#8217;s strengths in technology, talent, and innovation, particularly in the fields of AI and big data. The company will collaborate with the NMPA to study and construct a vertical large-scale model for drug regulation. This model will be the focus of in-depth training and development efforts.<\/p>\n\n\n\n<p><strong>Enhancing Drug Regulation with Data Analysis and AI<\/strong><br>The collaboration&#8217;s primary goal is to unlock the full potential of drug regulation data through deep mining and extensive data analysis. By doing so, the intelligence level and regulatory efficiency of drug regulation are expected to be significantly enhanced. This initiative will provide a scientific basis for decision-making, benefiting both government entities and enterprises in the pharmaceutical sector.<a href=\"https:\/\/flcube.com\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic&#8230;<\/p>\n","protected":false},"author":1,"featured_media":18236,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,838],"class_list":["post-18235","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ai","tag-neusoft-medical-systems"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic agreement with the Center for Information of the National Medical Products Administration (NMPA) of China. The collaboration aims to conduct in-depth research, innovative application, and practice exploration of artificial intelligence (AI) in the realm of drug intelligent administration. The joint efforts will be centered around the &quot;AI+drug intelligent administration&quot; R&amp;D application platform.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=18235\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration\" \/>\n<meta property=\"og:description\" content=\"Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic agreement with the Center for Information of the National Medical Products Administration (NMPA) of China. The collaboration aims to conduct in-depth research, innovative application, and practice exploration of artificial intelligence (AI) in the realm of drug intelligent administration. The joint efforts will be centered around the &quot;AI+drug intelligent administration&quot; R&amp;D application platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=18235\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-16T02:41:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-16T02:41:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1602.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration\",\"datePublished\":\"2024-12-16T02:41:30+00:00\",\"dateModified\":\"2024-12-16T02:41:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235\"},\"wordCount\":213,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1602.png\",\"keywords\":[\"AI\",\"Neusoft Medical Systems\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=18235#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=18235\",\"name\":\"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1602.png\",\"datePublished\":\"2024-12-16T02:41:30+00:00\",\"dateModified\":\"2024-12-16T02:41:33+00:00\",\"description\":\"Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic agreement with the Center for Information of the National Medical Products Administration (NMPA) of China. The collaboration aims to conduct in-depth research, innovative application, and practice exploration of artificial intelligence (AI) in the realm of drug intelligent administration. The joint efforts will be centered around the \\\"AI+drug intelligent administration\\\" R&D application platform.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=18235\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1602.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/1602.png\",\"width\":1080,\"height\":720,\"caption\":\"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18235#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration - Insight, China&#039;s Pharmaceutical Industry","description":"Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic agreement with the Center for Information of the National Medical Products Administration (NMPA) of China. The collaboration aims to conduct in-depth research, innovative application, and practice exploration of artificial intelligence (AI) in the realm of drug intelligent administration. The joint efforts will be centered around the \"AI+drug intelligent administration\" R&D application platform.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=18235","og_locale":"en_US","og_type":"article","og_title":"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration","og_description":"Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic agreement with the Center for Information of the National Medical Products Administration (NMPA) of China. The collaboration aims to conduct in-depth research, innovative application, and practice exploration of artificial intelligence (AI) in the realm of drug intelligent administration. The joint efforts will be centered around the \"AI+drug intelligent administration\" R&D application platform.","og_url":"https:\/\/flcube.com\/?p=18235","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-12-16T02:41:30+00:00","article_modified_time":"2024-12-16T02:41:33+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1602.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=18235#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=18235"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration","datePublished":"2024-12-16T02:41:30+00:00","dateModified":"2024-12-16T02:41:33+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=18235"},"wordCount":213,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=18235#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1602.png","keywords":["AI","Neusoft Medical Systems"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=18235#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=18235","url":"https:\/\/flcube.com\/?p=18235","name":"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=18235#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=18235#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1602.png","datePublished":"2024-12-16T02:41:30+00:00","dateModified":"2024-12-16T02:41:33+00:00","description":"Neusoft Medical Systems Co., Ltd, a leading Chinese medical technology company, has announced a strategic agreement with the Center for Information of the National Medical Products Administration (NMPA) of China. The collaboration aims to conduct in-depth research, innovative application, and practice exploration of artificial intelligence (AI) in the realm of drug intelligent administration. The joint efforts will be centered around the \"AI+drug intelligent administration\" R&D application platform.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=18235#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=18235"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=18235#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1602.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1602.png","width":1080,"height":720,"caption":"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=18235#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Neusoft Medical Systems and NMPA Collaborate on AI-Enhanced Drug Administration"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/1602.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18235"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18235\/revisions"}],"predecessor-version":[{"id":18237,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18235\/revisions\/18237"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/18236"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}